Navigation Links
Nu Skin Enterprises and Toyo Bio-Pharma Enter Agreement for Joint Product Research and Development
Date:7/28/2008

rements for skin care and supplements in Japan."

About Toyo Bio-Pharma

Toyo Bio-Pharma(TM) (http://www.toyobiopharma.com) is a subsidiary of Toyo Shinyaku Co., Ltd., a research-driven manufacturer committed to providing consumers and clients with high-value ingredients derived from nature. With the most advanced instrumentation, continuous research and commitment to quality and integrity, Toyo Shinyaku is pioneering the use of fermentation and culturing to produce beneficial, effective products for use in the nutraceutical, functional food and cosmeceuticals industries. Toyo Shinyaku is Japan's largest developer of FOSHU (Food for Specialized Health Use) products and ODM (Original Design Manufacturer) of supplement and skin care products. Toyo Shinyaku follows rigorous standards of ISO 9001:2000 and ISO 22000:2005, and was one of the first Japanese companies to become Food and Drug Administration (FDA) Good Manufacturing Practices (GMP)-compliant for food products and dietary supplements.

About Nu Skin Enterprises

Nu Skin Enterprises, Inc. is a global direct selling company operating in 47 markets throughout Asia, the Americas and Europe. The company markets premium-quality personal care products under the Nu Skin(R) brand, science-based nutritional supplements under the Pharmanex(R) brand, and technology-based products and services under the Big Planet(R) brand. Nu Skin Enterprises is traded on the New York Stock Exchange under the symbol "NUS." More information is available at http://www.nuskinenterprises.com.


'/>"/>
SOURCE Nu Skin Enterprises, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Nu Skin Enterprises to Announce Second Quarter 2008 Results
2. Medline Receives Force Majeure Notice From Hong Ray Enterprises
3. Nu Skin Enterprises to Present at Oppenheimer Consumer Growth Conference
4. BME (BioMedical Enterprises, Inc.) Announces U.S. Launch of the Barbed OSStaple(TM) (BOSS) Nitinol Implant
5. BME (BioMedical Enterprises, Inc.) Announces U.S. Launch of the OSSAnchor(TM) Grip Nitinol Soft Tissue Anchor
6. Nu Skin Enterprises Announces Slate of Candidates for its Board of Directors
7. Coventina Healthcare Enterprises, Inc. is Now ReGear Life Sciences, Inc.
8. Nu Skin Enterprises Declares Quarterly Dividend of $0.11
9. Nu Skin Enterprises Reports First-Quarter 2008 Results
10. FFF Enterprises Selects A10 Networks AX Series Advanced Traffic Manager
11. CJPS Enterprises Announces a Series of Seminars on Automotive Diversification
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/8/2009).../ -- Allscripts-Misys Healthcare,Solutions, Inc.,...llscripts or,the Company), today announced its fi...d November 30, 2008. , (Logo: http://www.n...) , The Company,s results for the three and...ts from legacy Allscripts for the period of Octobe...
(Date:1/8/2009).../ -- The Pew Charitable Trusts announced today tha...and food safety programs, in its Health & Huma... deputy staff director and general counsel of the ...brings nearly 25 years of experience in environmen...We are excited to be joined by such an experienced...
(Date:1/8/2009)...ine Siu and Jason Brown, Ph.D. Promoted to Vice Pr...FORD, Conn., Jan. 8 Thomas, McNern...irm that invests in life science and medical techn...three members of its investment team. Kathy Tune ... Jason Brown have been promoted to Vice President....
(Date:1/8/2009)...re/ -- A proposal by the State of Indiana to close...has prompted the 125,000-member American Legion De...r conference January 10-12, 2009, in order to orga...opposition to the proposal. , , The Legion, whi...nd in-kind support to the home, is among the forem...
Breaking Medicine News(10 mins):Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 2Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 3Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 4Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 5Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 6Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 7Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 8Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 9Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 10Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 11Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 12Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 13Health News:Veteran Environmental Health Expert Erik D. Olson to Join Pew 2Health News:Thomas, McNerney & Partners Promotes Three Members of Its Investment Team 2
...ound 10 million female fetuses may have been abort...ng to a study published online today by The Lancet...heir study Prabhat Jha (St. Michael's Hospital, Un...ar (Post-Graduate Institute of Medical Education a...
...ltimore has been named America's fittest city by M...st. According to the ranking accorded by the Men's... Baltimore were Honolulu, Virginia Beach, Va., Tuc...test cities behind Chicago were Las Vegas, Los Ang...
...inese Minister of Health Gao Qiang said China has ...cies, both treatment and prevention. // The SARS ...emic disease prevention and control system. The go...ps to address them, he said. After 27 billion yuan...
... least five people-three in Ankara and two in Van-... the bird flu virus, a Turkish official said on Su... of the health ministry's Basic Health Services, t...28 people were tested at a government laboratory i...
Other Medicine News:Health News:10 Million Indian Females Aborted In 20 years 2
(Date:1/6/2009)... Program Expands on Successful Results from prior ... 7 Vital Therapies, Inc. (VTI), a ... today announced patient enrollment has begun for ...inical trial that will study the Extracorporeal Li...ts with Acute Liver Failure (ALF) under three prot...
(Date:1/6/2009)... CAMBRIDGE, Mass., Jan. 6 Cequent ...ovel products to deliver RNAi-based treatments to ...e company has recently completed a successful toxi...ministered tk RNAi therapeutic targeting the prim...al adenomatous polyposis). FAP is an inherited gas...
(Date:1/5/2009)... SAN JOSE, Calif., Jan. 5 Wome... progesterone medication to help support early,pr... forms of this medication,can be painful for pati...ch,can be administered by subcutaneous injection ...with better patient tolerance. , With patie...
(Date:12/27/2008)... SAN DIMAS, Calif., Dec. 27 Ac...sers are best advised to consume modest doses of,... as typically provided in 3,to 5 glasses of aged,... (Photo: http://www.newscom.com/cgi-bin/prnh/200...ows mega-dose resveratrol alone fails to prolong,...
Breaking Medicine Technology:ELAD(R) Liver Support System Study Initiated at Multiple U.S. Centers 2ELAD(R) Liver Support System Study Initiated at Multiple U.S. Centers 3Cequent to Present First Proof of Activity of an Oral RNAi Drug in Non-Human Primates at February Keystone Conference 2Cequent to Present First Proof of Activity of an Oral RNAi Drug in Non-Human Primates at February Keystone Conference 3Fertility Physicians of Northern California Researchers Test New Forms of Progesterone Medication for Luteal Support During IVF 2Longevity Seekers Advised to Consume Modest Doses of Red Wine Molecules in Dietary Supplements (Longevinex(R)) Rather than Mega-Dose Resveratrol Alone 2Longevity Seekers Advised to Consume Modest Doses of Red Wine Molecules in Dietary Supplements (Longevinex(R)) Rather than Mega-Dose Resveratrol Alone 3Big Relief From the Big Easy Headed to Cedar Rapids Hospital 23654 1Big Relief From the Big Easy Headed to Cedar Rapids Hospital 23654 2Pelosi Statement on Senate Vote on Medicare Improvements Act 23649 1Researchers Gather to Address New Tools in Development for Breast Cancer Detection 23647 1Researchers Gather to Address New Tools in Development for Breast Cancer Detection 23647 2Researchers Gather to Address New Tools in Development for Breast Cancer Detection 23647 3Sonablate 28R 29 International HIFU Registry is the First Worldwide HIFU Clinical Registry for Prostate Cancer Treatments 2607 1Sonablate 28R 29 International HIFU Registry is the First Worldwide HIFU Clinical Registry for Prostate Cancer Treatments 2607 2Sonablate 28R 29 International HIFU Registry is the First Worldwide HIFU Clinical Registry for Prostate Cancer Treatments 2607 3
... - Elixir,Pharmaceuticals, Inc., today announced t...monstrating that ghrelin antagonism may be a,poten...abolic,disorders. These data demonstrated a variet...ing body weight, improvements in,blood glucose and...e data were presented in poster sessions on Sunday...
...re-FirstCall/ --,Genaera Corporation today announc...mine (MSI-1436) for the treatment of obesity were,... (ADA) 67th,Scientific Sessions, June 22-25 in Chi...ntist and lead author of Abstract #1801-P,present... that,Causes Differential Weight Loss, Reduces Adi...
Other Medicine Technology:Elixir Pharmaceuticals Presents Preclinical Data Highlighting Its,Ghrelin Antagonist Program at the American Diabetes Association's,Annual Meeting 2Elixir Pharmaceuticals Presents Preclinical Data Highlighting Its,Ghrelin Antagonist Program at the American Diabetes Association's,Annual Meeting 3Elixir Pharmaceuticals Presents Preclinical Data Highlighting Its,Ghrelin Antagonist Program at the American Diabetes Association's,Annual Meeting 4Genaera Presents Preclinical Data on Trodusquemine (MSI-1436) for,the Treatment of Obesity at the American Diabetes Association 67th,Scientific Session 2Genaera Presents Preclinical Data on Trodusquemine (MSI-1436) for,the Treatment of Obesity at the American Diabetes Association 67th,Scientific Session 3Genaera Presents Preclinical Data on Trodusquemine (MSI-1436) for,the Treatment of Obesity at the American Diabetes Association 67th,Scientific Session 4
Inquiry H Steerable Catheter. Steerable atrial mapping catheter offers a variety of designs and a unique 45 offset for catheter stability. 10 to 24 electrodes, regular and large steerable curves, ina
A steerable diagnostic catheter with optimal maneuverability
For Atrial Isthmus Mapping. Biosense Webster offers a complete line of specialty 20-pole catheters. The SANTORO Fixed Catheter is designed for simple subclavian access and placement in the coronary s
Standard Deflectable Catheters
Medicine Products: